Diversified CRO OpAns LLC operates as a contract research organization with capabilities spanning mass spectrometry, separations chemistry, pediatric clinical trial support, and micro-sampling using a patented dried bio-fluid collection device, serving government, pharmaceutical, agricultural, hospital, clinic, and judicial sectors. This breadth suggests cross-sell opportunities across research, development, and personalized testing services to both new and existing clients.

Clinical & Bioanalytical The company offers both non-clinical and clinical development studies, including pharmacokinetics, pharmacodynamics, safety assessments, biomarkers, and environmental bioanalytical testing (TOX21, ToxCast, EDSP). This positions OpAns to upsell end-to-end studies for clients expanding regulated workflows, especially those in pharma and environmental health sectors.

Pediatric & Micro-sampling Specialization in pediatric clinical trial support and micro-sampling with amasse dried bio-fluid collection devices highlights a niche proficiency that can be leveraged to win pediatric-focused trials, remote sampling programs, and trials requiring minimal invasiveness, appealing to sponsors prioritizing patient-friendly workflows.

Public Sector Footprint Active engagement with government agencies (EPA, NIH, NCATS) indicates established credibility in regulated environments. Sourcing opportunities exist in federal grant-backed studies, contract solicitations, and collaborative research opportunities that can broaden project pipelines beyond traditional pharma clients.

Growth Signals With a revenue range of 10 to 25 million and a mid-sized employee base, OpAns sits in a growth-ready band where expanding service lines, pursuing larger clinical and environmental contracts, and leveraging partner channels could accelerate deal size and win rates against peers in the CRO market.